Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

5.9%

2 terminated out of 34 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

62%

8 of 13 completed with results

Key Signals

8 with results87% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (11)
Early P 1 (1)
P 1 (5)
P 2 (8)
P 3 (1)

Trial Status

Completed13
Recruiting10
Active Not Recruiting4
Not Yet Recruiting2
Terminated2
Unknown1

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT03448926RecruitingPrimary

The PREDICT Registry:

NCT06902311Phase 2Recruiting

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

NCT02926911Not ApplicableActive Not RecruitingPrimary

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

NCT02492607Not ApplicableActive Not RecruitingPrimary

Management of Low-risk (Grade I and II) DCIS

NCT03878342Not ApplicableActive Not RecruitingPrimary

Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast

NCT06388304Not ApplicableCompleted

THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence

NCT07292246Not ApplicableRecruiting

A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)

NCT07178665Phase 1Suspended

Pilot Trial of Preop Partial Radiation in Breast Cancer Patients

NCT05900986Phase 1Active Not Recruiting

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

NCT03535506Phase 2TerminatedPrimary

Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery

NCT04797299RecruitingPrimary

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

NCT04084730Phase 2Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

NCT03936478Phase 2Recruiting

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer

NCT06860217Not ApplicableNot Yet Recruiting

Robotic Nipple Sparing Mastectomy with Immediate Reconstruction

NCT05912569Not ApplicableRecruitingPrimary

Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS

NCT06217458Not ApplicableNot Yet RecruitingPrimary

The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS

NCT04049214Not ApplicableRecruiting

Perioperative Mindfulness Proposal

NCT04245150CompletedPrimary

Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity

NCT05436808Early Phase 1Withdrawn

Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer

NCT02637024Phase 2Completed

Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation

Scroll to load more

Research Network

Activity Timeline